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Conclusions: Independent of low-density lipoprotein-cholesterol, HDL-C was associated
with better 1-year outcome in patients with ACS underwent elective PCI.
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Background: Longitudinal stent deformation (LSD) is a recently described
complication of PCI but mechanisms contributing to its occurrence and associated
clinical outcomes remain unclear. The FDA Manufacturer and User Facility
Device Experience (MAUDE) database is a voluntary international electronic
reporting system whose aim is to capture major adverse events involving medical
devices. We sought to identify cases of LSD reported to this database to gain
insight into procedural and anatomical factors that predispose to this complication
and associated clinical outcomes.
Methods: The MAUDE database was searched from 1992 until 31st October 2011
using 11 defined search terms. Individual reports identified using this search
strategy were studied for the presence of longitudinal stent deformation, defined
as the distortion or shortening of a stent in the longitudinal axis following
successful stent deployment.
Results: 57 unique cases of LSD were identified between 2004-2011. A significant
increase in the reporting of LSD in the last two years was observed with most reported
cases in stents based on the Element platform (90%). The lesions in which LSD was
reported were complex (vessel calcification 26%; tortuosity 25%; long 28%; ostial disease
21%) and most frequently occurred following attempts to pass or withdraw secondary
devices through a previously deployed stent (89% cases where mechanism identified).
The majority of cases required further treatment (79%) with further stent deployment
performed in 58% cases and balloon post-dilatation alone performed in 18% cases.
Adverse clinical outcomes including emergent cardiac surgery and acute and sub-acute
stent thrombosis occurred in 8 cases.
Conclusions: LSD is reported most commonly in cases of complex angiographic
disease. This complication can occur secondary to a variety of mechanisms and
identification and treatment is important, since adverse incidents such as emergent
CABG and stent thrombosis may occur. The recent increased reporting of this
complication appears to be related to the introduction of the Element stent
platform. A novel classification system is proposed to facilitate future reporting of
this complication.
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Background: Significant longitudinal compression has been clinically observed in cases
where drug-eluting coronary stents were crossed by other interventional devices. Our
objective was to characterize stent longitudinal resistance under simulated clinical worst
case crossing scenarios in good apposition and malapposition in-vitro models.
Methods: 6 commercially available coronary balloon-expandable stent designs were
evaluated. First direct parallel plates longitudinal crush resistance was conducted after
deploying 3 samples/design to 3 mm diameter. Then 12 samples/design were tracked over
a 0.014 interventional guidewire, positioned and deployed in either good apposition or
malapposition coronary vessel models, 6 samples each, respectively. After deployment and
withdrawal of the balloon, a new balloon was advanced over the guidewire automatically using
the IDTE 2000 (Interventional Device Testing Equipment, Machine Solutions, Inc, Flagstaff,
AZ, USA). For each sample, the force required to track the balloon through the stent and the
change in stent length after balloon crossing were both calculated.
Results: In the parallel plate crush test, 3 out of 6 stent designs demonstrated higher
longitudinal crush rates compared to the Resolute, Medtronic, Minneapolis USA (Promus
Element, Boston Scientific Corp., Natik USA & Coroflex Blue, BBraun, Melsungen
Germany, p0.001; Orsiro, Biotronik, Berlin Germany, p0.038). In the simulated use test,
longitudinal crush ranged from 5 to 22%; however, no statistically significant differences in
longitudinal crush were seen between stent types for both good apposition (p0.836) and
malapposition cases (p0.447). One stent type showed significantly higher longitudinal crush
(p0.027) in the malapposed model compared to the good apposition model.
Conclusions: Lower resistance to pure mechanical longitudinal crush of some stent
designs seen in bench testing did not correlate to significantly higher crush rates in good
simulated clinical conditions. Nevertheless, it would be useful to take account the rough
mechanical characteristics of some new stents to minimize longitudinal compression
during stent implantation.
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Background: Stent fracture (SF) has been frequently reported in clinical trials and it has
been associated with restenosis and thrombosis. In this study we aimed to determine the
predictors of stent fracture by using a single stent design in the porcine coronary model.
Methods: A total of 113 Cypher stents were implanted in normal coronary arteries at a
10% overstretch ratio in a single (81.4%), overlapping (30.6%) or T-bifurcation (19.4%)
stent configuration. At termination, we reviewed high-contrast film–based radiographs to
examine for the presence of SF. SF was graded as minor (2 SF), multiple (2 SF) and
major (multiple SF with complete transection or SF at multiple sites). Angiographic and
histo-morphometric data were compared between groups with SF and without SF
(non-SF).
Results: SF was found in 11 stents (9.5%; minor 3(27.3%), multiple 3(27.3%), and
major  5(45.5%)). SF was more commonly seen in longer stents (SF 19.94.8 mm
versus non-SF 14.33.2 mm, p0.001), T-bifurcation location (SF: 68.8% versus
non-SF: 10.9%, p0.001) and overlapping stents (SF: 75.0% versus non-SF: 22.8%,
p0.001). Angiographic restenosis (50%) was higher in the SF (33.3%) group
compared to non-SF (4.3%, p0.016) and it was found only on the multiple (1 of 3) or
major (2 of 5) SF groups. The presence of SF was associated with a greater degree of
histologically derived neointimal proliferation (neointimal area SF: 3.422.63 mm2
versus non-SF: 2.621.79 mm2 and % area stenosis SF: 43.119.5% versus non-SF:
36.620.6%). T-bifurcation location (OR [95%CI] 80.81[9.42, 693.52], p0.001) and
stent overlapping (OR [95%CI]  46.18[5.44, 391.72], p0.001) were identified as
independent predictors of SF.
Conclusions: At the experimental setting, the incidence of SF found was high. Specific
technical situations (i.e., overlapping stents) were predictors of SF and were associated to
higher degrees of neointimal proliferation. SF may be a strong contributor of stent failure
in complex technical situations.
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AMwww.jacc.tctabstracts2012.com
JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Stent Fracture and Longitudinal Deformation B155
P
O
ST
E
R
S
